Pfizer Acquires Metsera for $10 Billion, Enters Obesity Drug Market
After receiving the offer, Pfizer enters the highly lucrative obesity drug market, although Metsera’s products are ...
Search Result for 'obesity'
No Result
Ozempic Price Hike Drives Spike in Counterfeit Drug Cases
The United States Customs and Border (CBP) seized 11 shipments of counterfeit Ozempic at Cincinnati airport, ...
Novo Nordisk Announces $4 Billion Expansion to Meet Rising Ozempic Demand in the US
Novo Nordisk's market worth exceeds that of Denmark as a whole, and its shares have increased ...
Nestlé Under Fire for Sugar Addition in Infant Products Sold in Developing Nations
Nestle’s products in European markets did not have any sugar added, and where baby cereals for ...
Pfizer Shifts Focus to Cancer Drugs After Decline in Business Post-COVID-19
Pfizer Inc. is shifting its strategic focus from COVID to cancer pharmaceuticals in an effort to ...
Ozempic’s Success is Breaking Denmark’s Economy
Ozempic's unparalleled weight-loss effects swiftly captured global attention In 2022, Novo Nordisk, a Danish pharmaceutical company, ...
The Global Economics Limited is a UK based financial publication and a Bi-Monthly business magazine giving thoughtful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.
